Invasive Pneumococcal Disease among Adults: Associations among Serotypes, Disease Characteristics, and Outcome

被引:130
作者
Jansen, Angelique G. S. C. [2 ]
Rodenburg, Gerwin D. [2 ]
van der Ende, Arie [4 ,5 ]
van Alphen, Loek [6 ]
Veenhoven, Reinier H. [7 ]
Spanjaard, Lodewijk [4 ,5 ]
Sanders, Elisabeth A. M. [2 ]
Hak, Eelko [1 ,2 ,3 ]
机构
[1] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
[2] Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands
[5] Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands
[6] Netherlands Vaccine Inst, Bilthoven, Netherlands
[7] Spaame Hosp, Dept Pediat, Hoofddorp, Netherlands
关键词
STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; UNITED-STATES; CHILDREN; ERA; AGE;
D O I
10.1086/600045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The Streptococcus pneumoniae polysaccharide capsule may be related to invasive pneumococcal disease (IPD) course. Methods. We performed a retrospective cohort study with nationally representative surveillance data from 1075 hospitalized patients with IPD from the Netherlands from 1 June 2004 through 31 May 2006 in the prevaccination era. Serotypes were grouped according to invasive disease potential, rate of the most serious clinical syndromes of meningitis and bacteremia without focus, and case-fatality rates. Multivariable logistic regression analysis was performed to obtain odds ratios adjusted for baseline confounders for the association of serotypes and these outcomes, using the serotypes with the lowest rates as reference. Results. IPD caused by serogroups with low invasive disease potential concerned meningitis or bacteremia without focus in 22% of cases, and 74% of patients had an underlying comorbidity. For highly invasive serogroups these figures were 10% (P < .01) and 56% (P < .01). Individual serotypes varied in the relative rate by which they caused meningitis or bacteremia without focus. Compared with the reference group composed of serotypes 1, 5, 7F, 15B, 20, and 33F, the group of serotypes 3, 19F, 23A, 16F, 6B, 9N, and 18C was associated with increased case-fatality rates (group adjusted odds ratio, 2.6; 95% confidence interval, 1.5-4.7). Conclusions. The serotype appeared to be independently associated with IPD severity in adults, which indicates that careful monitoring of IPD after implementation of conjugate vaccines is necessary.
引用
收藏
页码:E23 / E29
页数:7
相关论文
共 17 条
[1]   Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults:: An international study [J].
Alanee, S. R. J. ;
McGee, L. ;
Jackson, D. ;
Chiou, C. C. ;
Feldman, C. ;
Morris, A. J. ;
Ortqvist, A. ;
Rello, J. ;
Luna, C. M. ;
Baddour, L. M. ;
Ip, M. ;
Yu, V. L. ;
Klugman, K. P. .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (01) :46-51
[2]   Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children [J].
Brueggemann, AB ;
Peto, TEA ;
Crook, DW ;
Butler, JC ;
Kristinsson, KG ;
Spratt, BG .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (07) :1203-1211
[3]   Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential [J].
Brueggemann, AB ;
Griffiths, DT ;
Meats, E ;
Peto, T ;
Crook, DW ;
Spratt, BG .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (09) :1424-1432
[4]  
de Greeff S C, 2007, Ned Tijdschr Geneeskd, V151, P1454
[5]   Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries [J].
Goossens, Herman ;
Ferech, Matus ;
Coenen, Samuel ;
Stephens, Peter .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (08) :1091-1095
[6]   Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004 [J].
Hicks, Lauri A. ;
Harrison, Lee H. ;
Flannery, Brendan ;
Hadler, James L. ;
Schaffner, William ;
Craig, Allen S. ;
Jackson, Delois ;
Thomas, Ann ;
Beall, Bernard ;
Lynfield, Ruth ;
Reingold, Arthur ;
Farley, Monica M. ;
Whitney, Cynthia G. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (09) :1346-1354
[7]   Nasopharyngeal colonization:: a target for pneumococcal vaccination [J].
Kayhty, Helena ;
Auranen, Kari ;
Nohynek, Hanna ;
Dagan, Ron ;
Makela, Helena .
EXPERT REVIEW OF VACCINES, 2006, 5 (05) :651-667
[8]   The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults [J].
Kyaw, MH ;
Rose, CE ;
Fry, AM ;
Singleton, JA ;
Moore, Z ;
Zell, ER ;
Whitney, CG .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03) :377-386
[9]   Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine [J].
Lexau, CA ;
Lynfield, R ;
Danila, R ;
Pilishvili, T ;
Facklam, R ;
Farley, MM ;
Harrison, LH ;
Schaffner, W ;
Reingold, A ;
Bennett, NM ;
Hadler, J ;
Cieslak, PR ;
Whitney, CG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (16) :2043-2051
[10]  
LUCERO MG, 2004, COCHRANE DB SYST REV, V18